Anti-Hu CD142 Purified

*Bucciarelli P, Martinelli I, Artoni A, Passamonti SM, Previtali E, Merati G, Tripodi A, Mannucci PM: Circulating microparticles and risk of venous thromboembolism. Thromb Res. 2012 May;129 (5) :591-7, URL: https://www.ncbi.nlm.nih.gov/pubmed/21908018, *Patil R, Ghosh K, Satoskar P, Shetty S: Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss. PLoS One. 2013 Nov 20;8 (11) :e81407., URL: https://pubmed.ncbi.nlm.nih.gov/24278436/, *Aass HC, Øvstebø R, Trøseid AM, Kierulf P, Berg JP, Henriksson CE: Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis. Cytometry A. 2011 Dec;79 (12) :990-9. doi: 10.1002/cyto.a.21147., URL: https://www.ncbi.nlm.nih.gov/pubmed/21990118, *Carson SD, Ross SE, Bach R, Guha A: An inhibitory monoclonal antibody against human tissue factor. Blood. 1987 Aug;70 (2) :490-3., URL: https://www.ncbi.nlm.nih.gov/pubmed/3607285, *Faulk WP, Labarrere CA, Carson SD: Tissue factor: Identification and characterization of cell types in human placentae. Volume 76, Issue 1, 1 July 1990, Pages 86-96., URL: https://www.sciencedirect.com/science/article/pii/S0006497120842633, *Virtanen S, Schulte R, Stingl J, Caldas C, Shehata M: High-throughput surface marker screen on primary human breast tissues reveals further cellular heterogeneity. Breast Cancer Res. 2021 Jun 13;23 (1) :66., URL: https://pubmed.ncbi.nlm.nih.gov/34120626/